LLLetai Li

Letai Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Letai Li has a total of 79 co-authors. Here are the top co-authors by number of shared publications:

  • Haibing Xiong

    Department of Neurosurgery, Banan Hospital Affiliated to Chongqing Medical University, Chongqing, China

    6 shared publications
  • Jiajie Leng

    School of Basic Medical Sciences , Chongqing Medical University , Chongqing , China , cqmu.edu.cn

    6 shared publications
  • Yingjiu Jiang

    Department of Cardiothoracic Surgery, The First Affiliated Hospital of Chongqing Medical University, China

    6 shared publications
  • Jiajie Leng

    Department of Cardiothoracic Surgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China

    5 shared publications
  • Haiyan Wang

    College of Basic Medical Sciences, Chongqing Medical University, Chongqing, China

    3 shared publications
  • Haofeng Xiong

    Banan Hospital Affiliated to Chongqing Medical University, Chongqing, China

    3 shared publications

Latest Publications

  • Open Access

    TyG‐HDL Outperforms TyG Combined With Obesity Indicators in Predicting Chronic Kidney Disease Associated With High Fasting Blood Glucose Levels in the Chinese Elderly Population: A Two‐Stage Study Based on GBD 2023 and CHARLS Data

    by Letai Li, Li Long, Tingting Chen, Xinhong Tian, Can Huang, Yutong Chen, Shiying Ye, Meng Ye, Jiajie Leng, Zhenrui Cao, et al.

    Background: Chronic kidney disease (CKD) is a major public health issue in China, especially among older adults, with rising prevalence linked to metabolic disorders such as hyperglycemia. This study aimed to assess the burden of CKD attributable to elevated fasting blood glucose (FBG) in elderly Chinese, focusing on the predictive value of composite metabolic indices derived from the triglyceride‐glucose (TyG) index. Method: The study included two phases: (1) analysis of the 2023 Global Burden of Disease (GBD) database to assess the CKD burden due to hyperglycemia among adults aged ≥ 60 years in China from 1990 to 2023 and (2) evaluation using the China Health and Retirement Longitudinal Study (CHARLS) cohort, analyzing associations between 15 blood glucose‐related indices and CKD in older adults. Results: The GBD analysis revealed a significant burden of CKD due to hyperglycemia in China, with increasing mortality and disability‐adjusted life years (DALYs) projections. In the CHARLS cohort, four indices—TyG‐HDL, TCBI, FBG‐HDL, and CTI—were significantly associated with CKD. Elevated levels of these indices, particularly TyG‐HDL, demonstrated strong associations with CKD risk, with nonlinear, threshold‐dependent effects observed in restricted cubic spline analyses. Conclusion: Blood glucose‐related indices, especially TyG‐HDL, offer strong predictive value for CKD risk in older Chinese adults. These findings suggest that integrating these indices into screening programs could enhance early CKD detection and management strategies, helping mitigate the growing disease burden in aging populations.

  • Open Access

    Systematic analysis of the global, regional, and national burden of peripheral artery disease from 1990 to 2021 and projections to 2040

    by Letai Li, Yaowen Zhang, Yanlin Li, Siyu Li, Haiyan Wang, Haibing Xiong, Hongtao Tie, Jiajie Leng

    Background: Peripheral artery disease (PAD) is a type of atherosclerotic vascular disease. Understanding its global burden and trends is essential to inform effective preventive strategies. Method: The Global Burden of Disease 2021 database was used to analyze trends in the burden of PAD from 1990 to 2021 and to assess temporal and spatial changes in the incidence, prevalence, deaths, and disability-adjusted life years of PAD. The Bayesian Age-Period-cohort model was used to predict future trends, and the burden distribution was explored using decomposition analysis, health inequality index, and sociodemographic index (SDI). Result: From 1990 to 2021, the global age standardization rate showed a consistent decline. However, absolute case numbers rose significantly, driven by population growth and aging. The burden was highest in high-SDI countries, while low- and middle-SDI countries experienced the most rapid increase. The gender gap suggested that older women should have been a major concern. The health inequality analysis showed that despite the narrowing of the relative gap, the absolute burden gap between high and low SDI countries continued to widen. The number of global PAD cases was expected to continue to rise by 2040, but the rate was expected to decline. Conclusion: Despite a decline in age-standardized rates, the absolute burden of PAD continues to grow due to demographic changes, with marked regional and demographic disparities. Targeted interventions and comprehensive management strategies are urgently needed to mitigate the growing public health impact of PAD worldwide.


  • PGC1α alleviates M1 macrophage polarization through dual regulation of succinate metabolism and TRAF5 expression to mitigate TLR4/NF-κB-driven inflammatory cascades and myocardial ischemia/reperfusion injury

    by Jiajie Leng, Zhenrui Cao, Letai Li, Dingheng Hu, Yuxiang Luo, Bin Tu, Xiaoying Cao, Rui Tao, Yingjiu Jiang, Hongtao Tie

    Objective This study investigates the dual regulatory role of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1α) in macrophage polarization and its therapeutic potential for mitigating myocardial ischemia/reperfusion injury (MI/RI). Methods By integrating in vivo murine myocardial MI/RI models with macrophage-specific genetic manipulation and multi-omics analyses, including transcriptomics, proteomics, and energy metabolomics, we comprehensively investigated the cardio-protective effects, immune regulation, and potential mechanism of PGC1α. Mechanistic validations were performed using macrophage hypoxia/reoxygenation models combined with gain- and loss-of-function experiments to elucidate the molecular interactions within the PGC1α-mediated signaling network. Results PGC1α emerged as a potential regulator of macrophage polarization through coordinated metabolic and protein regulation in MI/RI. It suppresses TLR4/NF-κB-driven inflammation via two prominent parallel pathways: (1) Metabolic control through SUCLG1/succinyl-CoA synthetase-mediated succinate generation; (2) negatively regulates protein by TRAF5 mRNA expression inhibition. This dual-axis regulation effectively dampens M1 macrophage polarization and pro-inflammatory cytokine storms. Furthermore, macrophage-specific PGC1α activation demonstrated cardio-protective effects by preserving cardiac function and reducing cardiomyocyte apoptosis. Conclusion Our findings established PGC1α as a potential regulator of macrophage polarization in MI/RI, bridging mitochondrial energy metabolism and protein expression with immune responses. The PGC1α-SUCLG1/succinate axis and PGC1α-TRAF5 axis unveil therapeutic targets and potential mechanisms for modulating inflammation in MI/RI. Future studies should focus on translating these mechanisms into clinical interventions through pharmacological PGC1α activation.


  • Open Access

    The global burden and trends of esophageal cancer caused by smoking among men from 1990 to 2021 and projections to 2040: An analysis of the Global Burden of Disease 2021

    by Zhenrui Cao, Haiyan Wang, Yanlin Li, Siying Ye, Jingyao Lin, Tuoyu Li, Jiajie Leng, Yingjiu Jiang, Mengjun Bie, Letai Li

    Esophageal cancer (EC) ranks 7th globally in cancer mortality, with smoking being a major preventable risk factor, particularly for squamous cell carcinoma predominant in Asia. This study quantifies the global burden of smoking-attributable EC among males using 2021 Global Burden of Disease data (1990–2021) and projects trends to 2040. Data on deaths and Disability-Adjusted Life Years (DALYs) for global burden of smoking-attributable EC among males were derived from the Global Burden of Diseases (GBD) Study 2021, along with the corresponding 95% uncertainty intervals (UIs). We analyzed with Joinpoint regression, age-period-cohort modeling for risk stratification, decomposition analysis, and Bayesian prediction. Global smoking-attributable EC deaths and DALYs among males decreased, concentrated in middle-to-high SDI regions. Age-standardized DALY rates (ASDR) declined significantly, with sharpest reductions in medium-SDI regions. East Asia bore disproportionate burden in China and Mongolia. Critical inflection occurred in 2004 by joinpoint and age-period-cohort analysis from 1990 to 2021. Mortality peak at 80–90 years and disability peak at 60–80 years. Decomposition analysis showed population growth and aging increased burden, offset by epidemiological improvements. Predictive analysis indicated stable-to-declining ASRs through 2040, contingent on sustained tobacco control in high-risk regions. The analysis indicated a global downward trend in EC attributable to smoking among males. While absolute burdens rise due to demographic pressures, declining ASRs reflect tobacco control progress. The 2004 inflection underscores policy impact, and East Asia's outsized burden necessitates targeted interventions. Our research underscores the profound influence of high BMI on EC attributable to smoking among males and provides a research foundation for future public health decision-making.


  • Open Access

    The global, regional and national burden of pancreatitis due to alcohol use: Results from the Global Burden of Disease Study 2021 and projections to 2040

    by Letai Li, Yaowen Zhang, Jiajie Leng, Siyu Li, Yang Lei, Zhenrui Cao, Yuxiang Luo, Haibing Xiong, Zhongjun Wu, Rui Tao, et al.

    Background: Alcohol use is a major risk factor for pancreatitis and global mortality. Despite its impact, comprehensive analyses of the burden across regions and sociodemographic strata remain scarce. This study examines global trends (1990–2021) and projects future burdens to 2040. Method: Data on Deaths and Disability-Adjusted Life Years (DALYs) attributable to alcohol-induced pancreatitis were retrieved from the 2021 iteration of the Global Burden of Diseases (GBD) database. Trends were analyzed, Age-Period-Cohort models quantified age, period, and cohort effects on Age-Standardized Mortality Rate (ASMR) and Age-Standardized Disability-Adjusted Life Year (ASDR). Associations with SDI were evaluated, burden decomposition applied, and projections made to 2040. Results: Globally, both age-standardized death rate (ASDR) and mortality ratio (ASMR) exhibited overall declines (EAPC for ASDR: −0.32%; ASMR: −0.27%), but the reduction was significantly smaller in males (ASDR-EAPC: −0.18%) compared to females (−1.34%). Notablly,Eastern Europe had the highest burden (ASDR: 64.03), High-income Asia-Pacific saw the largest declines (EAPC for ASDR: −2.45%; EAPC for ASMR: −2.96%), while Southeast Asia experienced the fastest increase (EAPC for ASDR: 1.98%; EAPC for ASMR: 2.13%). ASDR peaked at ages 45–49, with high-middle SDI countries showing the highest values. Period and cohort effects varied by SDI, with downward trends in high SDI countries and upward trends in lower SDI groups. Population growth and aging drove increases in deaths and DALYs, while epidemiologic changes reduced them. By 2040, deaths and DALYs will stabilize, ASMR will decline until 2034 then rise, and ASDR will decrease until 2035 then increase, driven by population growth. Conclusion: Alcohol-related pancreatitis burden demonstrates striking gender, age, and geographic heterogeneity. Targeted policies for high-risk groups (middle-aged/elderly males) and regions (Eastern Europe, Low-middle SDI countries), coupled with preparedness for aging-related burden escalation, are urgently needed.


  • Open Access

    Potential of vitamin D for the prevention of 3 types of cerebrovascular diseases: A 2-sample Mendelian randomization study

    by Letai Mb Li, Jiajie Leng, Haibing Xiong, Jianhong Huo, Yaowen Mb Zhang, Yang Mb Lei, Lin Mb Peng, Yuan Mb Huang, Yingjiu Jiang

    While nutritional and dietary interventions play a critical role in stroke prevention, the specific contributions of micronutrients remain incompletely understood. Observational studies suggest a potential association between vitamin D levels and cerebrovascular risk, but the causal role of vitamin D in distinct stroke subtypes – subarachnoid hemorrhage (SAH), intracerebral hemorrhage (ICH), and ischemic stroke (IS) – remains underexplored. Instrumental variables for vitamin D levels and stroke outcomes were derived from genome-wide association studies in the IEU Open genome-wide association studies database. A 2-sample Mendelian randomization (MR) framework was implemented to assess causal effects of vitamin D on SAH, ICH, and IS. The inverse variance weighted (IVW) method served as the primary analysis, supplemented by secondary analyses including weighted median, MR-Egger, and sensitivity assessments for pleiotropy (Cochran’ s Q-test, MR-PRESSO, MR-Egger intercept) and heterogeneity (leave-one-out analysis). Genetically predicted higher vitamin D levels demonstrated significant inverse associations with ICH risk (IVW odds ratio = 0.704, 95% CI: 0.584–0.904, P = .006) and IS risk (IVW odds ratio = 0.919, 95% CI: 0.849–0.995, P = .036), whereas no causal relationship was observed for SAH (IVW P = .091). Sensitivity analyses revealed no evidence of horizontal pleiotropy or influential outliers. This MR study provides novel genetic evidence supporting vitamin D as a protective factor against ICH and IS. Our findings highlight the potential clinical utility of vitamin D supplementation for cerebrovascular disease prevention, particularly in high-risk populations. Further investigations are warranted to elucidate biological mechanisms and validate these associations in diverse cohorts.

  • Open Access

    Hypertensive heart disease mortality trends attributable to high body mass index over the period 1990-2021 and projections up to 2040

    by Zhaohui Xu, Letai Li, Yinqin Hu, Jiahui Yang, Qiqi Wan, Xinyu Zhang, Rongjia Liu, Cheng Lu, Yongming Liu

    Introduction: This study aimed to evaluate trends in HHD mortality attributable to HBMI from 1990 to 2021 and projections up to 2040.Material and methods: Data on HHD mortality attributable to HBMI were obtained from the Global Burden of Diseases (GBD) 2021 database. Temporal trends in the burden of HHD attributable to HBMI were analyzed using generalized linear models to calculate the estimated annual percentage change (EAPC) in age-standardized mortality rates (ASMR) and age-standardized disability-adjusted life-years (DALYs) rates (ASDR) from 1990 to 2021.Results: From 1990 to 2021, the global ASMR for HHD attributable to HBMI increased from 6.83 (4.37 - 9.32) to 7.21 (4.23 - 9.94), with an EAPC value of 0.33 (0.27 - 0.39) for the ASMR. the ASDR increased from 144.72 (106.21 - 182.76) to 147.33 ( 109.06 - 183.45) with an EAPC value of 0.15 (0.1 - 0.21) for ASDR. Particularly severe ASMR and ASDR were observed in most countries in Africa and in a few countries along the Mediterranean coast. In contrast, most developed countries in North America, Europe, and Australia presented lower ASMR and ASDR. When the overall trend was divided into subsections, at the end of the study period, ASMR and ASDR for HHD attributable to HBMI showed a downward trend. By dividing the regions by SDI, middle SDI had the greatest fluctuation in ASMR and ASDR, and low SDI showed an increasing trend in ASMR and ASDR at the final joinpoint.Conclusions: Therefore, more targeted prevention approaches should be established to mitigate this growing trend.


  • Open Access

    Association of omega-3/6 polyunsaturated fatty acids with three cerebrovascular diseases: A Mendelian randomization study

    by Haibing Xiong, Letai Li, Jiayu Luo, Caiyun Jiao, Meng Ye, Yang Lei, Xin Guo, Shi Zeng, Jianhong Huo, Haofeng Xiong, et al.

    Nutritional and dietary interventions are important in the prevention of stroke, but many of the factors influencing stroke remain undefined. Although omega-3/6 polyunsaturated fatty acids (PUFAs) have been suggested to be associated with cerebrovascular diseases, studies on this topic are lacking. This study extracted and screened independent single nucleotide polymorphisms of omega-3/6 PUFAs and 3 types of cerebrovascular diseases data from the IEU Open GWAS database. A two-sample Mendelian randomization (MR) was used to examine the association between omega-3/6 PUFAs with subarachnoid hemorrhage (SAH), intracerebral hemorrhage (ICH), and ischemic stroke (IS). The primary analysis method was the inverse variance weighting method, supplemented by the weighted median and MR-Egger methods. Sensitivity and multiplicity were assessed using Cochran Q test, MR-PRESSO, MR-Egger regression, and leave-one-out analysis. This study was conducted in full compliance with the STROBE guidelines throughout. The inverse variance weighting analysis revealed a negative correlation between omega-3 PUFAs and SAH ( P = .0078). However, there was no correlation between omega-3 PUFAs and ICH ( P = .3930) and IS ( P = .2922). Additionally, there was no association between omega-6 PUFAs and SAH ( P = .1399), ICH ( P = .1399, 0.0660), and IS ( P = .8571) using all 3 analytical methods. No heterogeneity or horizontal pleiotropy was observed. The study suggested that omega-3 PUFAs had a significant protective role in SAH. However, omega-3/6 PUFAs were not found to be associated with other types of cerebrovascular diseases.

  • Open Access

    Mendelian Randomization Study Investigating the Causal Relationship Between Thyroid Dysfunction and Cerebral Infarction

    by Letai Li, Jiajie Leng, Haibing Xiong, Zishan Deng, Meng Ye, Haiyan Wang, Xin Guo, Shi Zeng, Haofeng Xiong, Jianhong Huo

    BACKGROUND: There is an association between thyroid dysfunction and cerebral infarction (CI), but the causality cannot be determined. A two‐sample two‐way Mendelian randomization (MR) study was conducted to assess the causal relationship between thyroid function and CI.METHODS: We selected single‐nucleotide polymorphisms (SNPs) associated with five phenotypes, including CI from the UK Biobank (n = 361,194), hyperthyroidism from the IEU Open GWAS database (n = 484,598), hypothyroidism from the IEU Open GWAS database (n = 473,703), normal thyroid‐stimulating hormone (TSH) (n = 271,040), and normal free thyroxine (FT4) (n = 119,120) from the Thyroidomics Consortium database. For the forward MR analysis, the exposures were hyperthyroidism, hypothyroidism, TSH, and FT4. The inverse variance weighted (IVW) method, weighted median (WM), and MR‐Egger revealed the causality with CI. For the reverse MR analysis, CI was regarded as the exposure, and four thyroid function phenotypes were the outcomes. The sensitivity and heterogeneity test was assessed using Cochran's Q test, MR‐Egger regression, and leave‐one‐out analysis.RESULTS: The MR analysis indicated that genetic susceptibility to hyperthyroidism increased the risk of CI (IVW‐OR = 1.070; 95% CI: 1.015–1.128; p = 0.003). In reverse MR, genetic susceptibility to RA is not associated with hyperthyroidism (IVW‐OR = 1.001; 95% CI: 1.000–1.001; p = 0.144). Any positive or reverse causal relationship between hypothyroidism, FT4, and TSH with CI could not be established. Sensitivity and heterogeneity test consolidated our findings.CONCLUSION: The causality between CI and hyperthyroidism demonstrated patients with hyperthyroidism have a risk of genetic variants for CI. In the future, further studies are needed to fully explore their mechanisms of action.